Par Pharmaceutical (PRX) Tops Q1 EPS by 8c

May 8, 2012 7:31 AM EDT
Get Alerts PRX Hot Sheet
Trade PRX Now!
Join SI Premium – FREE
Par Pharmaceutical (NYSE: PRX) reported Q1 EPS of $0.80, $0.08 better than the analyst estimate of $0.72. Revenue for the quarter came in at $271.5 million versus the consensus estimate of $230.84 million.

For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment